Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation
暂无分享,去创建一个
[1] B. Johansson,et al. Staphylokinase Control of Staphylococcus aureus Biofilm Formation and Detachment Through Host Plasminogen Activation. , 2016, The Journal of infectious diseases.
[2] J. O’Gara,et al. An Essential Role for Coagulase in Staphylococcus aureus Biofilm Development Reveals New Therapeutic Possibilities for Device-Related Infections. , 2015, The Journal of infectious diseases.
[3] S. Foster,et al. Staphylococcus aureus-induced clotting of plasma is an immune evasion mechanism for persistence within the fibrin network. , 2015, Microbiology.
[4] J. Parvizi,et al. Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. , 2015, The Journal of infectious diseases.
[5] J. Parvizi,et al. Staphylococcal Persistence Due to Biofilm Formation in Synovial Fluid Containing Prophylactic Cefazolin , 2015, Antimicrobial Agents and Chemotherapy.
[6] R. Darouiche,et al. Anti-biofilm agents in control of device-related infections. , 2015, Advances in experimental medicine and biology.
[7] G. Kahlmeter,et al. Biofilm Formation by Staphylococcus aureus Isolates from Skin and Soft Tissue Infections , 2015, Current Microbiology.
[8] P. Verhamme,et al. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections , 2014, BMC Microbiology.
[9] Timothy J. Foster,et al. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus , 2013, Nature Reviews Microbiology.
[10] E. Josefsson,et al. Staphylokinase promotes the establishment of Staphylococcus aureus skin infections while decreasing disease severity. , 2013, The Journal of infectious diseases.
[11] D. Missiakas,et al. The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections. , 2013, The Journal of infectious diseases.
[12] Carla Renata Arciola,et al. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. , 2012, Biomaterials.
[13] C. Wolz,et al. Two Distinct Coagulase-Dependent Barriers Protect Staphylococcus aureus from Neutrophils in a Three Dimensional in vitro Infection Model , 2012, PLoS pathogens.
[14] P. Verhamme,et al. Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence , 2011, Journal of thrombosis and haemostasis : JTH.
[15] A. Horswill,et al. New approaches for treating staphylococcal biofilm infections , 2011, Annals of the New York Academy of Sciences.
[16] E. Josefsson,et al. Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease , 2011, Inflammation Research.
[17] L. Rodrigues,et al. Inhibition of bacterial adhesion on medical devices. , 2011, Advances in experimental medicine and biology.
[18] T. Foster,et al. Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. , 2010, The Journal of infectious diseases.
[19] L. Visai,et al. The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. , 2009, Biomaterials.
[20] S. Eick,et al. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. , 2009, International journal of antimicrobial agents.
[21] M. Bokarewa,et al. Staphylokinase reduces plasmin formation by endogenous plasminogen activators , 2008, European journal of haematology.
[22] James D Bryers,et al. Medical biofilms. , 2008, Biotechnology and bioengineering.
[23] R. Andersson,et al. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden , 2007, Scandinavian journal of infectious diseases.
[24] G. O’Toole,et al. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] S. Kadam,et al. Plasminogen activators: a comparison. , 2006, Vascular pharmacology.
[26] M. Bokarewa,et al. Urokinase-type plasminogen activator, an endogenous antibiotic. , 2005, The Journal of infectious diseases.
[27] Z. Ikezawa,et al. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. , 2005, Journal of dermatological science.
[28] Haluk Beyenal,et al. Three-dimensional biofilm structure quantification. , 2004, Journal of microbiological methods.
[29] A. Gristina. Biomaterial-centered infection: microbial adhesion versus tissue integration. 1987. , 2004, Clinical orthopaedics and related research.
[30] V. Fowler,et al. Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. , 2003, Journal of medical microbiology.
[31] S. Stepanović,et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. , 2000, Journal of microbiological methods.
[32] H. Akiyama,et al. Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. , 1997, Journal of dermatological science.
[33] A. Gristina,et al. Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.